Turnstone Biologics Corp. (TSBX) Misses Q2 EPS by 455c

Turnstone Biologics Corp. (NASDAQ: TSBX) reported Q2 EPS of ($7.56), $4.55 worse than the analyst estimate of ($3.01).

For earnings history and earnings-related data on Turnstone Biologics Corp. (TSBX) click here.

You May Also Be Interested In

• SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
• ONEOK Inc (OKE) PT Raised to $95 at Scotiabank
• Ascendis Pharma (ASND) PT Lowered to $304 at BofA Securities